ArcheNova Technology Co., Ltd to acquire ArcheNova Biotech Corp.

ArcheNova Technology Co., Ltd has agreed to acquire ArcheNova Biotech Corp. in a transaction valued at two billion US dollars. The deal, announced on 13 October 2026, involves the purchase of the healthcare company through a share-based consideration structure. Both the acquirer and the target entity are registered in the Cayman Islands. The headline offer represents the total value of the proposed transaction, which aims to take the biotech firm private. This move consolidates the ownership structure within the ArcheNova group, shifting the target from public listing to private control under the technology subsidiary. The transaction reflects a strategic realignment within the corporate family, utilising equity as the primary form of payment rather than cash. No completion date has been reported for this agreement, indicating that the process is still in its early stages. The firm intention status suggests that the parties have reached a definitive understanding, although the deal has not yet closed. Regulatory approvals and other standard closing conditions remain outstanding for this cross-border entity transaction.